Frazier Life Sciences Acquisition Corp. II Class A Ordinary Shares

Frazier Life Sciences Acquisition Corp. II Class A Ordinary Shares(FLSC)股票分析

$10.210

+0.010 (+0.10%)收盤時

Loading chart…
最高
10.290
開盤
10.290
成交量加權均價
10.23
成交量
2.53K
市值
—
最低
10.180
成交金額
25.88K
企業價值/稅息折舊攤銷前利潤(TTM)
0.00

AI 分析 of Frazier Life Sciences Acquisition Corp. II Class A Ordinary Shares (FLSC)

持有

Frazier Life Sciences Acquisition Corp. II is currently trading at $10.16, which is 25.6% of its 52-week range between $10.00 and $10.62. The stock has shown a year-to-date change of +1.60%, indicating some stability. However, with a lack of significant insider or hedge fund activity and a neutral market context, it may be prudent to hold rather than buy at this time. The main risk is the recent 5-day change of -1.17%, suggesting potential downward momentum.

估值指標

Frazier Life Sciences Acquisition Corp. II Class A Ordinary Shares(FLSC)目前預期本益比為 0.00,5 年平均預期本益比為 。

預期本益比

5 年均值 P/E
目前P/E
0.00

預期 EV/EBITDA

5 年均值 EV/EBITDA
目前EV/EBITDA
0.00

預期股價營收比

5 年均值 P/S
目前P/S
0.00

FLSC 常見問題 —— 由 Alphio AI 解答

Frazier Life Sciences Acquisition Corp. II is currently trading at $10.16, which is 25.6% of its 52-week range between $10.00 and $10.62. The stock has shown a year-to-date change of +1.60%, indicating some stability. However, with a lack of significant insider or hedge fund activity and a neutral market context, it may be prudent to hold rather than buy at this time. The main risk is the recent 5-day change of -1.17%, suggesting potential downward momentum.

暫無貼文

註冊或登入後參與討論

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易